
Blood-Based Prognostic Prediction Model for Glioblastoma: Construction and Validation
Introduction Glioblastoma (GBM) is the most prevalent and aggressive cerebral malignancy in adults, characterized by a dismal prognosis.1 The median survival of GBM patients treated with surgery and the Stupp regimen ranges from only 14 to 24 months, and …